Literature DB >> 21412631

Evaluation of the quality of life of clients with chronic ischemic pain.

Débora Fernanda Amaral Pedrosa1, Andressa Karina Amaral Plá Pelegrin, Hilze Benigno de Oliveira Moura Siqueira, Talita de Cássia Raminelli da Silva, Orlando Carlos Gomes Colhado, Fátima Aparecida Emm Faleiros Sousa.   

Abstract

The evaluation of quality of life (QOL) faced with chronic ischemic pain involves the clients in their subjectivity and multidimensionality. This descriptive study aimed to evaluate the quality of life of clients who presented chronic ischemic pain. A total of 100 clients of hospital institutes participated in the study. The instrument used to assess pain was an 11 point numerical scale, and to assess the quality of life, the World Health Organization Quality of Life-abbreviated questionnaire. The arithmetic mean for chronic pain was 5.59 ± 3.16 points. The means for quality of life were: in the physical domain, 44.75 ± 16.98; in the overall domain, 50.0 ± 22.40; in the environment, 55.06 ± 13.51, in the psychological, 56.21 ± 17.19 and in the social domain, 68.33 ± 21.84. Thus, the physical domain was, among the areas analyzed, the one which presented a greater impact on the quality of life of the clients with chronic ischemic pain.

Entities:  

Mesh:

Year:  2011        PMID: 21412631     DOI: 10.1590/s0104-11692011000100010

Source DB:  PubMed          Journal:  Rev Lat Am Enfermagem        ISSN: 0104-1169


  2 in total

1.  Systematic review of pharmacological therapies for the management of ischaemic pain in patients with non-reconstructable critical limb ischaemia.

Authors:  Áine Ní Laoire; Fliss E M Murtagh
Journal:  BMJ Support Palliat Care       Date:  2017-08-23       Impact factor: 3.568

2.  Impact of neuropathic pain at the population level.

Authors:  Ana Shirley Maranhao Vieira; Abrahao Fontes Baptista; Livia Mendes; Kamilla Soares Silva; Sharize Cristine de Araujo Gois; Flavia Manoela de Almeida Lima; Israel Souza; Katia Nunes Sa
Journal:  J Clin Med Res       Date:  2014-02-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.